Premium
Cell‐Free Vascular Grafts That Grow with the Host
Author(s) -
Nasiri Bita,
Row Sindhu,
Smith Randall J.,
Swartz Daniel D.,
Andreadis Stelios T.
Publication year - 2020
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.202005769
Subject(s) - elastin , calcification , extracellular matrix , materials science , vascular smooth muscle , tissue engineering , anatomy , biomedical engineering , microbiology and biotechnology , smooth muscle , medicine , biology , pathology
Cell‐free small diameter vascular grafts, based on small intestinal submucosa functionalized with heparin and vascular endothelial growth factor (VEGF) are manufactured and implanted successfully into the arterial system of neonatal lambs, where they remain patent and grow in size with the host to a similar extent and with similar rate as native arteries. Acellular tissue engineered vessels (A‐TEVs) integrate seamlessly into the native vasculature and develop confluent, functional endothelium that affords patency. The medial layer is infiltrated by smooth muscle cells, shows no signs of calcification, and develops contractile function. The vascular wall undergoes remarkable extracellular matrix remodeling exhibiting elastin fibers and even inner elastic lamina within six months. Taken together, the results suggest that VEGF‐based A‐TEVs may be suitable for treatment of congenital heart disorders to alleviate the need for repeated surgeries, which are currently standard practice.